Elastin-like polypeptides (ELPs) are stimulus-responsive biopolymers derived from human
elastin. Their unique properties—including lower critical solution temperature phase …

Targeted drug delivery refers to an established therapeutic strategy that develops platforms
and nanoscale devices for selective delivery of small drug molecules and therapeutic genes …

Among the available potential colloidal drug carrier systems, protein-based nanocarriers are
particularly interesting. Meeting requirements such as low cytotoxicity, abundant renewable …

New strategies to self-assemble biocompatible materials into nanoscale, drug-loaded
packages with improved therapeutic efficacy are needed for nanomedicine. To address this …

Artificial repetitive polypeptides have grown in popularity as a bioinspired alternative to
synthetic polymers. The genetically encoded synthesis, monodispersity, potential lack of …

Elastin-like polypeptides (ELPs) are biopolymers inspired by human elastin. Their lower
critical solution temperature phase transition behavior and biocompatibility make them …

Packaging clinically relevant hydrophobic drugs into a self-assembled nanoparticle can
improve their aqueous solubility, plasma half-life, tumour-specific uptake and therapeutic …

Highlights•Limitations of conjugating poly (ethylene glycol) to proteins and peptides have
become increasingly apparent.•Various polymers have shown promise as PEG …

Peptides are emerging as a new class of biomaterials due to their unique chemical,
physical, and biological properties. The development of peptide-based biomaterials is …

Conventional drug delivery systems are challenged by concerns related to systemic toxicity,
repetitive doses, drug concentrations fluctuation, and adverse effects. Various drug delivery …